Persistence of Bactericidal Activity at 4 Years After 2 Primary Doses of a Recombinant, 4-Component, Meningococcal Serogroup B Vaccine (4CMenB) and Response to a Booster Dose in Adolescents and Young Adults

BACKGROUND: This phase 3b, open label, controlled, multi-center, extension study (NCT02446743) assessed the persistence of bactericidal activity at 4 years post-primary vaccination with a recombinant, 4-component, meningococcal serogroup B vaccine (4CMenB) in adolescents who participated in the pare...

Descripción completa

Detalles Bibliográficos
Autores principales: Nolan, Terry, Garfield, Hartley, Gupta, Anil, Ferguson, Murdo, Marshall, Helen, D’Agostino, Diego, Toneatto, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632200/
http://dx.doi.org/10.1093/ofid/ofx163.757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632200/
http://dx.doi.org/10.1093/ofid/ofx163.757

Ejemplares similares